Asthma flare-ups and breathing management survey
Part of Lungs & breathing clinical trials.
This study surveys doctors who treat patients with asthma. It aims to understand how asthma attacks are managed in real-world practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a practicing physician who sees asthma patients in your work.
- You are not an undergraduate medical student who is not yet practicing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how asthma attacks are managed in children and teens ages 6 to 17 who come to the emergency department. It aims to improve treatment for acute asthma flare-ups.
This study looks at people with asthma to understand what raises the risk of having frequent asthma attacks and how these attacks affect long-term health. The goal is to find ways to better predict and help manage these flare-ups.
This Phase 4 study looks at what causes breathing airways to narrow during asthma worsening, in people with stable, treated asthma. It may help improve how clinicians understand and manage asthma flare-ups.
This study tests a new way to improve care for adults with asthma who have had a recent severe attack. It aims to see if better management can prevent future flare-ups.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
This trial tests a remote monitoring device that tracks your breathing while you're at home. If you have asthma and are having a flare-up today, you may be able to use a small wearable sensor and a smartphone app to help your doctor keep an eye on your condition.
Hear when a new Acute Asthma Exacerbations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.